Agreements strengthen proprietary foundation, enhance partnering readiness, and support regulatory pathways for next-generation molecular diagnostics in neurology
Agreements strengthen proprietary foundation, enhance partnering readiness, and support regulatory pathways for next-generation molecular diagnostics in neurology